Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 336

1.

Application of optical coherence tomography in percutaneous coronary intervention.

Kubo T, Tanaka A, Kitabata H, Ino Y, Tanimoto T, Akasaka T.

Circ J. 2012;76(9):2076-83. Epub 2012 Jul 31. Review.

3.

Impact of frequency-domain optical coherence tomography guidance for optimal coronary stent implantation in comparison with intravascular ultrasound guidance.

Habara M, Nasu K, Terashima M, Kaneda H, Yokota D, Ko E, Ito T, Kurita T, Tanaka N, Kimura M, Ito T, Kinoshita Y, Tsuchikane E, Asakura K, Asakura Y, Katoh O, Suzuki T.

Circ Cardiovasc Interv. 2012 Apr;5(2):193-201. doi: 10.1161/CIRCINTERVENTIONS.111.965111. Epub 2012 Mar 27.

4.

Predictors of periprocedural (type IVa) myocardial infarction, as assessed by frequency-domain optical coherence tomography.

Porto I, Di Vito L, Burzotta F, Niccoli G, Trani C, Leone AM, Biasucci LM, Vergallo R, Limbruno U, Crea F.

Circ Cardiovasc Interv. 2012 Feb 1;5(1):89-96, S1-6. doi: 10.1161/CIRCINTERVENTIONS.111.965624. Epub 2012 Jan 31.

5.

Difference in neointimal appearance between early and late restenosis after sirolimus-eluting stent implantation assessed by optical coherence tomography.

Ino Y, Kubo T, Kitabata H, Ishibashi K, Tanimoto T, Matsuo Y, Shimamura K, Shiono Y, Orii M, Komukai K, Yamano T, Yamaguchi T, Hirata K, Tanaka A, Mizukoshi M, Imanishi T, Akasaka T.

Coron Artery Dis. 2013 Mar;24(2):95-101. doi: 10.1097/MCA.0b013e32835c872b.

PMID:
23363984
6.

Optical coherence tomography: from research to clinical application.

Alfonso F, Sandoval J, Cárdenas A, Medina M, Cuevas C, Gonzalo N.

Minerva Med. 2012 Dec;103(6):441-64. Review.

PMID:
23229366
7.

Optical coherence tomography for evaluation of coronary stents in vivo.

Nammas W, Ligthart JM, Karanasos A, Witberg KT, Regar E.

Expert Rev Cardiovasc Ther. 2013 May;11(5):577-88. doi: 10.1586/erc.13.37. Review.

PMID:
23621140
8.

Ex vivo assessment of neointimal characteristics after drug-eluting stent implantation: Optical coherence tomography and histopathology validation study.

Imanaka T, Fujii K, Hao H, Shibuya M, Saita T, Kawakami R, Fukunaga M, Kawai K, Tamaru H, Miki K, Horimatsu T, Sumiyoshi A, Nishimura M, Hirota S, Masuyama T, Ishihara M.

Int J Cardiol. 2016 Oct 15;221:1043-7. doi: 10.1016/j.ijcard.2016.07.110. Epub 2016 Jul 9.

PMID:
27447812
9.

The role of optical coherence tomography in coronary intervention.

Terashima M, Kaneda H, Suzuki T.

Korean J Intern Med. 2012 Mar;27(1):1-12. doi: 10.3904/kjim.2012.27.1.1. Epub 2012 Feb 28. Review.

10.

Coronary plaque response after drug eluting stent implantation assessed by serial optical coherence tomography analysis.

Tian F, Chen YD, Chen L, Sun ZJ, Liu CF, Guo J, Jin QH, Wang JD, Gai LY.

Chin Med J (Engl). 2011 Nov;124(22):3752-6.

PMID:
22340236
11.

Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation.

Kang SJ, Mintz GS, Akasaka T, Park DW, Lee JY, Kim WJ, Lee SW, Kim YH, Whan Lee C, Park SW, Park SJ.

Circulation. 2011 Jun 28;123(25):2954-63. doi: 10.1161/CIRCULATIONAHA.110.988436. Epub 2011 Jun 6.

12.

Optimal visualization of five different stent layers during and after percutaneous coronary intervention for recurrent in-stent restenosis using optical coherence tomography (OCT).

Movahed MR, Ram V, Arsanjani R.

Cardiovasc Revasc Med. 2012 Sep-Oct;13(5):292-4. doi: 10.1016/j.carrev.2012.05.001. Epub 2012 Jun 23.

PMID:
22727600
13.

Impact of coronary plaque morphology assessed by optical coherence tomography on cardiac troponin elevation in patients with elective stent implantation.

Lee T, Yonetsu T, Koura K, Hishikari K, Murai T, Iwai T, Takagi T, Iesaka Y, Fujiwara H, Isobe M, Kakuta T.

Circ Cardiovasc Interv. 2011 Aug;4(4):378-86. doi: 10.1161/CIRCINTERVENTIONS.111.962506. Epub 2011 Jul 26.

14.

Optical coherence tomography– 15 years in cardiology.

Yonetsu T, Bouma BE, Kato K, Fujimoto JG, Jang IK.

Circ J. 2013;77(8):1933-40. Epub 2013 Jul 12. Review.

15.

Recent advances in intracoronary imaging techniques: focus on optical coherence tomography.

Kubo T, Akasaka T.

Expert Rev Med Devices. 2008 Nov;5(6):691-7. doi: 10.1586/17434440.5.6.691. Review.

PMID:
19025345
16.

OCT demonstrating neoatherosclerosis as part of the continuous process of coronary artery disease.

Zhang BC, Karanasos A, Regar E.

Herz. 2015 Sep;40(6):845-54. doi: 10.1007/s00059-015-4343-y. Review.

17.

[Optical coherence tomographic analysis of in-stent neoatherosclerosis in lesions with restenosis after drug-eluting stent implantation].

Liu ZJ, Shi B, Deng CC, Xu GX, Zhao RZ, Shen CY, Wang ZL, Liu HL.

Zhonghua Xin Xue Guan Bing Za Zhi. 2018 Jan 24;46(1):44-49. doi: 10.3760/cma.j.issn.0253-3758.2018.01.008. Chinese.

PMID:
29374937
18.

Incidence, predictors, morphological characteristics, and clinical outcomes of stent edge dissections detected by optical coherence tomography.

Chamié D, Bezerra HG, Attizzani GF, Yamamoto H, Kanaya T, Stefano GT, Fujino Y, Mehanna E, Wang W, Abdul-Aziz A, Dias M, Simon DI, Costa MA.

JACC Cardiovasc Interv. 2013 Aug;6(8):800-13. doi: 10.1016/j.jcin.2013.03.019. Epub 2013 Jul 17.

19.

Optical coherence tomography-based predictors for creatine kinase-myocardial band elevation after elective percutaneous coronary intervention for in-stent restenosis.

Lee SY, Hong MK, Shin DH, Kim JS, Kim BK, Ko YG, Choi D, Jang Y.

Catheter Cardiovasc Interv. 2015 Mar;85(4):564-72. doi: 10.1002/ccd.25643. Epub 2014 Sep 1.

PMID:
25158217
20.

Comprehensive overview of definitions for optical coherence tomography-based plaque and stent analyses.

Di Vito L, Yoon JH, Kato K, Yonetsu T, Vergallo R, Costa M, Bezerra HG, Arbustini E, Narula J, Crea F, Prati F, Jang IK; COICO group (Consortium of Investigators for Coronary OCT).

Coron Artery Dis. 2014 Mar;25(2):172-85. doi: 10.1097/MCA.0000000000000072. Review.

PMID:
24356250

Supplemental Content

Support Center